臨床前 CRO 市場，按服務、按類型、按動物模型、按模型系統、按應用、按最終用戶、按地區

Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography

出版日期: 2025年05月05日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球臨床前 CRO 市場規模估計為 67.6 億美元，預計到 2032 年將達到 122.1 億美元，2025 年至 2032 年的複合年成長率為 8.82%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	67.6億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	8.82%	2032年價值預測	122.1億美元

近年來，全球臨床前 CRO 市場顯著成長，這得益於製藥和生技公司對外包臨床前研究活動日益成長的需求。臨床前合約組織 (CRO) 在藥物發現和研發過程中發揮著至關重要的作用，提供廣泛的服務，包括毒性測試、藥物動力學和動態測試以及動物模型開發。透過簡化藥物開發的臨床前階段，這些組織使製藥公司能夠專注於其核心競爭力，並加速新治療方法的上市。臨床前 CRO 市場競爭激烈，幾家主要企業在全球範圍內營運，提供專業服務和先進技術，以滿足客戶不斷變化的需求。隨著製藥業繼續面臨研發成本上升和監管審查加強等挑戰，預計未來幾年對臨床前 CRO 服務的需求將進一步成長。

市場動態：

全球臨床前CRO市場受多種因素驅動，包括製藥和生物技術公司日益增加的臨床前研究活動外包、對專業臨床前服務的需求不斷成長，以及壓縮藥物開發成本和時間的需求。將臨床前研究委託給CRO，使公司無需投入大量資本即可獲得專業知識、先進技術和最先進的設施。此外，藥物開發日益複雜，以及需要遵守嚴格的監管要求，進一步推動了對臨床前CRO服務的需求。然而，臨床前研究成本高昂、熟練專家數量有限以及與資料安全和智慧財產權保護相關的挑戰等因素可能會抑制市場成長。儘管有這些挑戰，但由於3D細胞培養、器官晶片和In Silico模擬等先進技術的日益普及，臨床前CRO市場仍顯示出巨大的成長機會，這些技術有助於提高臨床前研究的可預測性和效率。此外，個人化醫療需求的不斷成長以及對罕見疾病和孤兒藥的日益關注預計將在未來幾年為臨床前 CRO 創造新的商機。

本研究的主要特點

本報告對全球臨床前 CRO 市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和復合年成長率。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
全球臨床前 CRO 市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行的分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球臨床前 CRO 市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球臨床前 CRO 市場的各種策略矩陣來簡化決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 6.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.82%	2032 Value Projection:	USD 12.21 Bn

The global preclinical CRO market has witnessed significant growth in recent years, driven by the increasing demand for outsourcing preclinical research activities by pharmaceutical and biotechnology companies. Preclinical Contract Research Organizations (CROs) play a crucial role in the drug discovery and development process, providing a wide range of services such as toxicology testing, pharmacokinetic and pharmacodynamic studies, and animal model development. These organizations help streamline the preclinical phase of drug development, enabling pharmaceutical companies to focus on their core competencies and accelerate the delivery of new therapies to the market. The preclinical CRO market is highly competitive, with several key players operating globally, offering specialized services and advanced technologies to meet the evolving needs of their clients. As the pharmaceutical industry continues to face challenges such as rising research and development costs and increasing regulatory scrutiny, the demand for preclinical CRO services is expected to grow further in the coming years.

Market Dynamics:

The global preclinical CRO market is driven by several factors, including the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, the growing demand for specialized preclinical services, and the need to reduce drug development costs and timelines. Outsourcing preclinical studies to CROs allows companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, without the need for significant capital investments. Additionally, the increasing complexity of drug development, coupled with the need to comply with stringent regulatory requirements, has further fueled the demand for preclinical CRO services. However, the market growth may be restrained by factors such as the high cost of preclinical studies, the limited availability of skilled professionals, and the challenges associated with data security and intellectual property protection. Despite these challenges, the preclinical CRO market presents significant opportunities for growth, driven by the increasing adoption of advanced technologies such as 3D cell culture, organ-on-a-chip, and in silico modeling, which can help improve the predictivity and efficiency of preclinical studies. Moreover, the growing demand for personalized medicine and the increasing focus on rare diseases and orphan drugs are expected to create new opportunities for preclinical CROs in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global preclinical CRO market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preclinical CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories, Covance (Labcorp), WuXi AppTec, ICON plc, PPD (Part of Thermo Fisher Scientific), Medpace, Evotec SE, Syneos Health, BioReliance (Merck KGaA), Charles River, KCR, Parexel International, Inotiv, Toxikon, and Harlan Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preclinical CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical CRO market

Market Segmentation

Service Insights (Revenue, USD Bn, 2020 - 2032)
- Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- GLP
- Non-GLP
- Compound Management
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Others
Type Insights (Revenue, USD Bn, 2020 - 2032)
- Patient-Derived Organoid (PDO) Models
- Patient-Derived Xenograft (PDX) Models
Animal Model Insights (Revenue, USD Bn, 2020 - 2032)
- Small Animal Model
- Large Animal Model
Model System Insights (Revenue, USD Bn, 2020 - 2032)
- In Vivo
- In Vitro
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Metabolic Disorders
- Others
End Users Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Research Institutes and Universities
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Charles River Laboratories
- Covance (Labcorp)
- WuXi AppTec
- ICON plc
- PPD (Part of Thermo Fisher Scientific)
- Medpace
- Evotec SE
- Syneos Health
- BioReliance (Merck KGaA)
- Charles River
- KCR
- Parexel International
- Inotiv
- Toxikon
- Harlan Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preclinical CRO Market, By Service
- Global Preclinical CRO Market, By Type
- Global Preclinical CRO Market, By Animal Model
- Global Preclinical CRO Market, By Model System
- Global Preclinical CRO Market, By Application
- Global Preclinical CRO Market, By End Users
- Global Preclinical CRO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preclinical CRO Market, By Service, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Bioanalysis and DMPK studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - In vitro ADME
  - In-vivo PK
Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - GLP
  - Non-GLP
Compound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Process R&D
  - Custom Synthesis
  - Others
Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Medicinal Chemistry
  - Computation Chemistry
Safety Pharmacology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Preclinical CRO Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Patient-Derived Organoid (PDO) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patient-Derived Xenograft (PDX) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Preclinical CRO Market, By Animal Model, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Preclinical CRO Market, By Model System, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
In Vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
In Vitro
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Preclinical CRO Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Preclinical CRO Market, By End Users, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutes and Universities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Preclinical CRO Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covance (Labcorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD (Part of Thermo Fisher Scientific)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioReliance (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toxikon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Harlan Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies